Stay updated on Dolutegravir for HIV Treatment Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir for HIV Treatment Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record describes a completed dolutegravir expanded-access study for people with HIV and integrase resistance, including its eligibility criteria, study design, locations, and outcome measures. It also provides collaborator and investigator information and study-record dates.
    Difference
    70%
    Check dated 2026-11-11T02:08:16.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision indicator changes from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:35:30.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition was added above the 403 error page, and the site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:37:01.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:52:54.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, including the HTML snippet for the 403 page and a Home link, indicating access is blocked and the underlying study details are not visible.
    Difference
    16%
    Check dated 2026-09-23T00:38:42.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays the revision label v3.7.0, replacing the previous v3.6.6. This metadata update signals a new page version without changing the study details.
    Difference
    0.0%
    Check dated 2026-09-16T00:09:16.000Z thumbnail image

Stay in the know with updates to Dolutegravir for HIV Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.